U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 212779

Expand all

POTASSIUM CITRATE (POTASSIUM CITRATE)
10MEQ
Marketing Status: Prescription
Active Ingredient: POTASSIUM CITRATE
Proprietary Name: POTASSIUM CITRATE
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 10MEQ
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A212779
Product Number: 001
Approval Date: Jan 14, 2020
Applicant Holder Full Name: ANI PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information
POTASSIUM CITRATE (POTASSIUM CITRATE)
15MEQ
Marketing Status: Prescription
Active Ingredient: POTASSIUM CITRATE
Proprietary Name: POTASSIUM CITRATE
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 15MEQ
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A212779
Product Number: 002
Approval Date: Jan 14, 2020
Applicant Holder Full Name: ANI PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top